As of 2025-06-02, the EV/EBITDA ratio of Boston Therapeutics Inc (BTHE) is -4.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BTHE's latest enterprise value is 9.84 mil USD. BTHE's TTM EBITDA according to its financial statements is -2.02 mil USD. Dividing these 2 quantities gives us the above BTHE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |